Fidelity International
BPMC

Fidelity International’s Blueprint Medicines BPMC Stock Holding History

Fidelity International’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,759,500
Closed -$226M – 1001
2025
Q2 		$226M Buy
+1,759,500
New +$183M 0.19% 129
2018
Q3 		– Sell
-742,848
Closed -$47.2M – 930
2018
Q2 		$47.2M Buy
+742,848
New +$59.1M 0.07% 264
2017
Q2 		– Sell
-172,497
Closed -$6.9M – 518
2017
Q1 		$6.9M Sell
172,497
-84,500
-33% -$3.03M 0.02% 381
2016
Q4 		$7.21M Sell
256,997
-372,067
-59% -$11.2M 0.02% 364
2016
Q3 		$18.7M Sell
629,064
-174,495
-22% -$4.33M 0.06% 256
2016
Q2 		$16.3M Hold
803,559
– – 0.05% 281
2016
Q1 		$14.5M Hold
803,559
– – 0.04% 295
2015
Q4 		$21.2M Buy
+803,559
New +$18.1M 0.06% 241

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Fidelity International's BPMC Position: Q3 2025 in Review

Fidelity International sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 1,759,500 shares — an estimated $226M sold.

Fidelity International first reported a position in BPMC in Q4 2015 and held it in 8 quarters. The position peaked at $226M in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • Fidelity International reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • Fidelity International sold 1,759,500 Blueprint Medicines shares in Q3 2025, an estimated $226M.
  • Fidelity International first reported a position in Blueprint Medicines in Q4 2015 and held it in 8 quarters.
  • Fidelity International's Blueprint Medicines position peaked at $226M in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Fidelity International's 13F filing for Q3 2025, filed 13 Nov 2025.